安图生物
(603658)
| 流通市值：202.74亿 | | | 总市值：202.74亿 |
| 流通股本：5.71亿 | | | 总股本：5.71亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,127,156,171.6 | 2,060,307,179.95 | 995,933,663.32 | 4,471,202,509.22 |
| 营业收入 | 3,127,156,171.6 | 2,060,307,179.95 | 995,933,663.32 | 4,471,202,509.22 |
| 二、营业总成本 | 2,294,860,260.37 | 1,506,453,270.45 | 746,443,403.96 | 3,307,150,305.92 |
| 营业成本 | 1,099,754,181.57 | 732,834,381.85 | 347,853,931.15 | 1,546,573,971.03 |
| 税金及附加 | 43,820,703.41 | 27,676,624.21 | 11,685,533.86 | 48,316,292.22 |
| 销售费用 | 588,929,376.21 | 389,039,334.86 | 195,260,976.79 | 767,766,504.11 |
| 管理费用 | 163,164,328.7 | 102,288,423.93 | 58,570,851.1 | 210,881,373.71 |
| 研发费用 | 392,925,176.19 | 250,345,849.36 | 130,563,085.75 | 731,932,785.27 |
| 财务费用 | 6,266,494.29 | 4,268,656.24 | 2,509,025.31 | 1,679,379.58 |
| 其中:利息费用 | 11,878,575.69 | 9,517,542.81 | 5,583,446.15 | 22,281,972.04 |
| 其中:利息收入 | 4,280,372.11 | 2,480,460.15 | 1,017,384.07 | 20,565,513.62 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -2,656,044.42 | -54,112.42 | 649,979.05 | 3,609,780.75 |
| 加:投资收益 | 86,016,772.34 | 67,250,439.05 | 23,449,847.26 | 92,272,195.9 |
| 资产处置收益 | -3,315.41 | 38,609.84 | 37,110.02 | -1,169,696.21 |
| 资产减值损失(新) | -12,967,991.55 | -14,215,837.01 | 402,957.8 | -62,954,217.56 |
| 信用减值损失(新) | -4,405,590.05 | 1,913,032 | 9,988,165.74 | -55,606,118.47 |
| 其他收益 | 53,916,907.55 | 28,025,398.61 | 19,480,632.72 | 105,284,799.74 |
| 四、营业利润 | 952,196,649.69 | 636,811,439.57 | 303,498,951.95 | 1,245,488,947.45 |
| 加:营业外收入 | 18,307,958.53 | 9,879,032.7 | 1,264,348.54 | 62,790,815.15 |
| 减:营业外支出 | 11,330,294.22 | 7,845,037.1 | 2,624,860.36 | 19,223,288.41 |
| 五、利润总额 | 959,174,314 | 638,845,435.17 | 302,138,440.13 | 1,289,056,474.19 |
| 减:所得税费用 | 86,449,225.68 | 60,808,445.42 | 29,058,717.66 | 89,823,194.3 |
| 六、净利润 | 872,725,088.32 | 578,036,989.75 | 273,079,722.47 | 1,199,233,279.89 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 872,725,088.32 | 578,036,989.75 | 273,079,722.47 | 1,199,233,279.89 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 859,515,131.82 | 571,001,185.83 | 269,880,235.57 | 1,194,451,909.72 |
| 少数股东损益 | 13,209,956.5 | 7,035,803.92 | 3,199,486.9 | 4,781,370.17 |
| 扣除非经常损益后的净利润 | 815,477,646.46 | 546,316,646.83 | 256,895,204.32 | 1,098,820,497.48 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 1.5 | 1.02 | 0.47 | 2.07 |
| (二)稀释每股收益 | 1.5 | 1.02 | 0.47 | 2.07 |
| 八、其他综合收益 | -84,048.63 | -8,422.01 | -12,112 | 106,410.67 |
| 归属于母公司股东的其他综合收益 | -84,048.63 | -8,422.01 | -12,112 | 106,410.67 |
| 九、综合收益总额 | 872,641,039.69 | 578,028,567.74 | 273,067,610.47 | 1,199,339,690.56 |
| 归属于母公司股东的综合收益总额 | 859,431,083.19 | 570,992,763.82 | 269,868,123.57 | 1,194,558,320.39 |
| 归属于少数股东的综合收益总额 | 13,209,956.5 | 7,035,803.92 | 3,199,486.9 | 4,781,370.17 |
| 公告日期 | 2025-10-30 | 2025-08-22 | 2025-04-18 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |